New York City Event on May 2; Los Angeles Event on May 9
Revlon® Introduces New
Color Collection to Support the Fight Against Women’s Cancers
Revlon, Lilly Tartikoff and the Entertainment Industry Foundation™
(EIF) announced that Revlon® brand ambassadors Jennifer Connelly, Jessica
Alba, and Jessica Biel along with NBC late night host
Jimmy Fallon will host the 2009 EIF Revlon Run/Walk for
Women in New York taking place on Saturday, May 2, 2009.
Hosting the Los Angeles event the following week on Saturday, May 9 during
Mother's Day weekend, will be Emmy-nominated star of ABC's "Samantha
Who" Christina Applegate along with actress, singer and star
of "Hannah Montana" Miley Cyrus, her mother Tish
Cyrus, Revlon brand ambassador Beau Garrett and special guest
and star of ABC's "Dancing with the Stars" Carrie Ann Inaba.
The EIF Revlon Run/Walk event, launched in 1993 through the combined
efforts of Lilly Tartikoff, Ronald O. Perelman, chairman of Revlon, and
EIF, is one of the nation's largest single-day fundraisers to support
women's cancer research, counseling and outreach programs. Since
inception, nearly $55 million in grants have been made from the combined
events in New York and Los Angeles.
The 12th annual New York City 5K race starts in Times Square and
finishes in Central Park. The 16th annual Los Angeles 5K race takes
place at the Los Angeles Memorial Coliseum at Exposition Park. Together,
these events are expected to attract 100,000 participants.
"Hundreds of thousands of women and men have come out year after year to
support the cause and for loved ones who have been personally affected
by cancer. Their devotion and commitment to finding a cure is what has
made the EIF Revlon Run/Walk so successful," says Ronald O. Perelman,
chairman of Revlon, Inc., co-founder of the EIF Revlon Run/Walk, and
co-founder of the Revlon/UCLA Women's Cancer Research Program. "Through
significant advancement in education and research, so many women today
have resources and treatments available to them and with that aid they
are beating the odds and surviving cancer."
Proceeds from past EIF Revlon Run/Walks have funded cutting-edge
research, contributing to the development of the breakthrough gene
treatment Herceptin® as well as other targeted therapies, bringing new
and innovative treatment approaches to women's cancers worldwide.
